ARKG is trading 3.1% down today as investors rotate away from higher-risk biotech and genomics names despite a generally mixed broader market.
- The healthcare and biotech complex is seeing profit-taking after recent strength.
- Sentiment is dampened by macro growth concerns and risk-off flows evident in crypto and other speculative assets.